Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-09

Clinical Trial Update: The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating rhythm evaluation for anticoagulation with continuous monitoring in atrial fibrillation is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Johns Hopkins University | Conditions: Atrial Fibrillation | Phase 3 | Status: RECRUITING